BDPT.D Stock Overview
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
BioAdaptives, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.05 |
| 52 Week High | US$0.42 |
| 52 Week Low | US$0.01 |
| Beta | 0.35 |
| 11 Month Change | -82.46% |
| 3 Month Change | -72.22% |
| 1 Year Change | -83.33% |
| 33 Year Change | -99.17% |
| 5 Year Change | -99.89% |
| Change since IPO | -99.92% |
Recent News & Updates
Recent updates
Shareholder Returns
| BDPT.D | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -16.7% | 4.3% | 2.2% |
| 1Y | -83.3% | -12.0% | 31.6% |
Return vs Industry: BDPT.D underperformed the US Personal Products industry which returned -11.6% over the past year.
Return vs Market: BDPT.D underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| BDPT.D volatility | |
|---|---|
| BDPT.D Average Weekly Movement | 82.5% |
| Personal Products Industry Average Movement | 8.6% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BDPT.D's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: BDPT.D's weekly volatility has increased from 49% to 83% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 4 | James Keener | www.shopbioadaptives.com |
BioAdaptives, Inc. investigates, markets, and distributes natural plant, algal, and mushroom-based products and medical devices for humans and animals. It offers nutraceutical products, such as dietary supplements. The company offers PluriPain, a fast acting long lasting natural pain relief formulation; PrimiLungs; MindNMemory, a nootropic formulation that enhances memory, focus, mental clarity, and endurance; PrimiSleep, a natural soporific that aids relaxation and sleep quality; Cell Rejuven that increases energy and mobility and resistance to stress, activates primitive cells, improves wound healing, and promotes hair and nail growth; and ProteinNMore, which builds lean bulk muscle, and promotes muscle contractility and strength, as well as helps in improving blood flow.
BioAdaptives, Inc. Fundamentals Summary
| BDPT.D fundamental statistics | |
|---|---|
| Market cap | US$205.29k |
| Earnings (TTM) | -US$795.67k |
| Revenue (TTM) | US$19.87k |
10.3x
P/S Ratio-0.3x
P/E RatioIs BDPT.D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| BDPT.D income statement (TTM) | |
|---|---|
| Revenue | US$19.87k |
| Cost of Revenue | US$94.49k |
| Gross Profit | -US$74.62k |
| Other Expenses | US$721.05k |
| Earnings | -US$795.67k |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.19 |
| Gross Margin | -375.55% |
| Net Profit Margin | -4,004.40% |
| Debt/Equity Ratio | -19.4% |
How did BDPT.D perform over the long term?
See historical performance and comparison